aDepartment of Microbiology, Hamadan University of Medical Sciences, Hamadan, Iran
bBrucellosis Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
Copyright © 2017 Korea Centers for Disease Control and Prevention
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
CONFLICTS OF INTEREST
No potential conflict of interest relevant to this article was reported.
Gene target | Primer sequence (5′ to 3′) | Amplicon/product size (bp) | Reference |
---|---|---|---|
intI1 |
F: CAGTGGACATAAGCCTGTTC R: CCCGACGCATAGACTGTA |
160 | [33] |
intI2 |
F: TTGCGAGTATCCATAACCTG R: TTACCTGCACTGGATTAAGC |
288 | [33] |
3CS,5CS |
F: GGCATCCAAGCAGCAAG R: AAG CAG ACT TGA CCT GA |
Variable | [34] |
mecA |
F: TCCAGATTACAACTTCACCAGG R: CCACTTCATATCTTGTAACG |
162 | [35] |
Type I |
F: GCTTTAAAGAGTGTCGTTACAGG R: GTTCTCTCATAGTATGACGTCC |
613 | [5] |
Type II |
F: GATTACTTCAGAACCAGGTCAT R: TAAACTGTGTCACACGATCCAT |
287 | [36] |
Type III |
F: CATTTGTGAAACACAGTACG R: GTTATTGAGACTCCTAAAGC |
243 | [35] |
Type IV |
F: GCCTACTCTTCTGAAAAGCGTCG R: CTTATTCGAAGAAACCG |
776 | [5] |
Type V |
F: GAACATTGTTACTTAAATGAGCG R: TGAAAGTTGTACCCTTGACACC |
325 | [5] |
Gene target | Primer sequence (5′ to 3′) | Amplicon/product size (bp) | Reference |
---|---|---|---|
intI1 | F: CAGTGGACATAAGCCTGTTC R: CCCGACGCATAGACTGTA | 160 | [ |
intI2 | F: TTGCGAGTATCCATAACCTG R: TTACCTGCACTGGATTAAGC | 288 | [ |
3CS,5CS | F: GGCATCCAAGCAGCAAG R: AAG CAG ACT TGA CCT GA | Variable | [ |
mecA | F: TCCAGATTACAACTTCACCAGG R: CCACTTCATATCTTGTAACG | 162 | [ |
Type I | F: GCTTTAAAGAGTGTCGTTACAGG R: GTTCTCTCATAGTATGACGTCC | 613 | [ |
Type II | F: GATTACTTCAGAACCAGGTCAT R: TAAACTGTGTCACACGATCCAT | 287 | [ |
Type III | F: CATTTGTGAAACACAGTACG R: GTTATTGAGACTCCTAAAGC | 243 | [ |
Type IV | F: GCCTACTCTTCTGAAAAGCGTCG R: CTTATTCGAAGAAACCG | 776 | [ |
Type V | F: GAACATTGTTACTTAAATGAGCG R: TGAAAGTTGTACCCTTGACACC | 325 | [ |
Antimicrobial agent | MR-CoNS (n = 50) | MS-CoNS (n = 50) | ||||
---|---|---|---|---|---|---|
|
| |||||
S. saprophyticus (n = 2) | S. haemolyticus (n = 23) | S. epidermidis (n = 25) | S. saprophyticus (n = 2) | S. haemolyticus (n = 17) | S. epidermidis (n = 31) | |
Clindamycin | 0 | 5 | 4 | 0 | 4 | 6 |
| ||||||
Chloramphenicol | 0 | 7 | 8 | 0 | 2 | 6 |
| ||||||
Doxycycline | 0 | 2 | 7 | 0 | 6 | 10 |
| ||||||
Erythromycin | 0 | 9 | 4 | 1 | 4 | 12 |
| ||||||
Cefoxitin | 2 | 23 | 25 | 0 | 0 | 0 |
| ||||||
Gentamicin | 0 | 6 | 8 | 1 | 2 | 3 |
| ||||||
Levoflxacin | 0 | 3 | 1 | 1 | 2 | 5 |
| ||||||
Novobiocin | 2 | 0 | 0 | 2 | 1 | 0 |
| ||||||
Rifampicin | 1 | 0 | 0 | 0 | 1 | 2 |
| ||||||
Trimethoprim-sulfamethoxazole | 1 | 13 | 14 | 1 | 5 | 14 |
| ||||||
Vancomycin | 0 | 0 | 0 | 0 | 0 | 0 |
Species | Source | Integron class | Gene cassette | SCCmec typing |
---|---|---|---|---|
S. epidermidis | Urine | 1 | – | NT |
Blood | 1 | – | V | |
Wound | 1 | – | III | |
Urine | 1 | – | NT | |
Blood | 1 | – | III | |
Blood | 1 | aadA1 | V | |
Catheter | 1 | aadA1 | I | |
Blood | 1 | aadA1 | NT | |
Blood | 1 | – | NT | |
Urine | 2 | – | III | |
Blood | 2 | – | I | |
S. haemolyticus | Blood | 1 | – | NT |
Urine | 1 | – | II | |
Blood | 1 | – | NT | |
Blood | 1 | – | III | |
Urine | 1 | – | NT | |
Urine | 1 | aadA1 | V | |
Urine | 1 | aadA1 | III | |
Blood | 2 | – | II | |
Urine | 2 | – | V |
Species | SCCmec typing (No. of isolates) | |||||
---|---|---|---|---|---|---|
I | II | III | IV | V | NT | |
S. epidermidis (n = 14) | 0 | 1 | 8 | 3 | 0 | 2 |
S. haemolyticus (n = 14) | 1 | 3 | 2 | 1 | 7 | 0 |
S. saprophyticus (n = 2) | 0 | 0 | 0 | 0 | 0 | 2 |
MR, methicillin-resistant; CoNS, coagulase-negative staphylococci; MS, methicillin-sensitive;
MR-CoNS, methicillin-resistant coagulase-negative staphylococci; SC-Cmec, staphylococcal cassette chromosome
SCCmec, staphylococcal cassette chromosome